Phase Ib of L-NMMA and Pembrolizumab
Phase 1 Completed
12 enrolled 15 charts
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
Phase 1 Completed
17 enrolled
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors
Phase 1 Completed
28 enrolled
TICIMEL
Phase 1 Completed
33 enrolled
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Phase 1 Completed
19 enrolled
A Study of DF6002 Alone and in Combination With Nivolumab
Phase 1 Completed
170 enrolled
Study of DF6215 in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
MK-4700-001
Phase 1 Completed
5 enrolled
PALANGI3
Phase 1 Completed
26 enrolled
Lipo-MERIT
Phase 1 Completed
119 enrolled
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Phase 1 Completed
62 enrolled 17 charts
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Phase 1 Completed
25 enrolled 14 charts
IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma
Phase 1 Completed
17 enrolled
Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
Phase 1 Completed
27 enrolled
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Phase 1 Completed
23 enrolled
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Phase 1 Completed
10 enrolled
Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
Phase 1 Completed
26 enrolled 24 charts
Trial to Investigate GZ21T in Healthy Volunteers
Phase 1 Completed
41 enrolled 17 charts
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
Phase 1 Completed
97 enrolled
IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
Phase 1 Completed
51 enrolled
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Phase 1 Completed
10 enrolled
A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
Phase 1 Completed
15 enrolled 8 charts
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
Phase 1 Completed
10 enrolled
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
Phase 1 Completed
53 enrolled
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
Phase 1 Completed
89 enrolled
Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies
Phase 1 Completed
46 enrolled
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
Phase 1 Completed
13 enrolled
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Phase 1 Completed
31 enrolled
HAITILS
Phase 1 Completed
8 enrolled
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
Phase 1 Completed
23 enrolled
Dendritic Cell Activating Scaffold in Melanoma
Phase 1 Completed
23 enrolled
Comparison of Nicotinamide Treatments for Actinic Keratosis
Phase 1 Completed
74 enrolled
ARC-12
Phase 1 Completed
94 enrolled
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
Phase 1 Completed
134 enrolled 37 charts
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
Phase 1 Completed
10 enrolled
GeniusVac-Mel4
Phase 1 Completed
9 enrolled
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
Phase 1 Completed
146 enrolled 38 charts
TUNINTIL
Phase 1 Completed
17 enrolled
TRX518-001
Phase 1 Completed
10 enrolled
Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma
Phase 1 Completed
45 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy
Phase 1 Completed
199 enrolled
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Phase 1 Completed
272 enrolled
Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
Phase 1 Completed
17 enrolled
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Phase 1 Completed
185 enrolled
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Phase 1 Completed
100 enrolled
Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
DISCOVER
Phase 1 Completed
11 enrolled
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
Phase 1 Completed
25 enrolled 9 charts
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
Phase 1 Completed
17 enrolled 15 charts